CUTANEOUS SQUAMOUS CELL CARCINOMA COURSES
The incidence of cutaneous squamous cell carcinoma (cSCC) are growing in the United States and epidemiologic and outcomes data are likely to have underestimated the burden of the disease. New therapies are emerging for the management of advanced cSCC that have the potential to meaningfully alter outcomes for a select group of patients who are unlikely to be cured with surgery.
The CME-accredited educational curricula provided here by RMEI are designed to engage practicing clinicians with actionable insights for improving the delivery of patient care. Some of the world’s foremost clinical experts on cSCC are featured as faculty, in video and audio dialogues, with real patients. New activities and live meetings are added regularly, so be sure to check back for updates!